Novel salt forms of a 4h-pyran-4-one structured CYP11a1 inhibitor

TW202631605APending Publication Date: 2026-08-01ORION CORP(FI)
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
ORION CORP(FI)
Filing Date
2022-03-01
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001071864_001
    Figure TWG2TA001071864_001
  • Figure TWG2TA001071864_002
    Figure TWG2TA001071864_002
  • Figure TWG2TA001071864_003
    Figure TWG2TA001071864_003
Patent Text Reader

Abstract

The present invention relates to novel salts, particularly crystalline salts, of 2-(isoindolin-2-ylmethyl)-5-((1-(methylsulfonyl)piperidin-4-yl)methoxy)-4H-pyran-4-one (I) which are particularly suitable for use in the manufacture of pharmaceutical compositions. Furthermore, the invention relates to pharmaceutical compositions comprising such novel salts. Compound (I) is a selective inhibitor of CYP11A1 enzyme and is useful in the treatment of hormonally regulated cancers, such as prostate cancer and breast cancer.
Need to check novelty before this filing date? Find Prior Art